European Society of Gastrointestinal Endoscopy recommends capsule sponge testing for Barrett's esophagus

The European Society of Gastrointestinal Endoscopy (ESGE) has published an update to the Barett's esophagus guidelines for diagnosis and management and highlighted the high-quality evidence for capsule sponge testing.

This officially sets out guidance for practitioners and patients on using non-endoscopic, minimally-invasive cell collection, like Cyted's EndoSign®, as an alternative to endoscopy that can proactively care for oesophageal health and find oesophageal cancer earlier.

Capsule Sponge Testing in Action

This minimally-invasive procedure collects cell samples from the entire length of the esophagus, which are then analyzed. Based on the test results, healthcare professionals can efficiently triage patients. Those with concerning findings can be prioritized for urgent endoscopy, while others can be more easily monitored on a regular basis, ensuring timely intervention when needed.

Adopting Capsule Sponge Testing

For enquiries on implementing this transformative test, contact us at hello@cyted.ai

Join us in the journey towards better esophageal health, streamlined triage, and enhanced patient care.

For more on the guidelines, click here (external link).